# Sperm Bank, Inc – FDA Inspection, Jun 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/sperm-bank-inc/097ab2fc-d0bb-47cc-ae3c-847c5c7c41f9
Source feed: FDA_Inspections

> FDA inspection 1241773 of Sperm Bank, Inc, June 12, 2024. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 1271. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241773
- Company Name: Sperm Bank, Inc
- Inspection Date: 2024-06-12
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1287950 - 2025-10-15](https://www.keypedia.com/records/fda_inspections/sperm-bank-inc/d25027ef-852a-4c3c-abde-67f9f3eec541)
- FDA Inspection 1085581 - 2019-02-28
- FDA Inspection 1037747 - 2017-12-12
- [FDA Inspection 587399 - 2009-06-12](https://www.keypedia.com/records/fda_inspections/sperm-bank-inc/4b334f39-2c2d-49d6-bc9f-933e3ffa6f4e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kellie-l-thommes/255a1b92-cd56-41f5-9622-82e8a629e153)

Company: https://www.keypedia.com/companies/sperm-bank-inc/c1078c0d-e7d2-4107-a710-06d0d24a7184

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
